Affiliated Hospital of Yangzhou University Researchers Discuss Research in Liver Cancer (Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and ...)

Press/Media: Research

PeriodDec 11 2024

Media coverage

1

Media coverage

  • TitleAffiliated Hospital of Yangzhou University Researchers Discuss Research in Liver Cancer (Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and ...)
    Media name/outletCancer Daily
    Country/TerritoryUnited States
    Date11/12/24
    PersonsYang Yang